"The benefits of antidepressants is based upon just one probability, one which has been debunked as non-scientific by many academics. The risks of taking antidepressants are reported side effects, including self-harm, suicidal thoughts and suicide completion. And we are **still** told by Dr's, pharmaceutical companies and medicine regulators that the benefits outweigh the risks. This is an incorrect statement.."

~ Bob Fiddaman

Monsanto Roundup Lawsuit

Wednesday, May 18, 2011

GSK JAPAN - PAXIL STUDY IN KIDS UPDATE

Well, I'd love to tell you that the Paxil study in children that was carried out in Japan was deemed a failure. Truth is, I don't know and Glaxo, it appears, remain to be tight lipped over this particular study.

A few days ago I wrote how they [GSK] had promised to get back to me regarding my query of the outcome of the NCT00812812 clinical trial, "Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)"

Remarkably the Clinical Trials webpage has now been updated regarding this trial...no conclusion though.

The study was completed back in February this year [2011].

Glaxo wrote me this morning with the following:

Thank you for contacting the GSK Clinical Support Helpdesk.

Unfortunately conclusion can’t be disclosed before the official CTR is released.

Adding in a further email:

The expected official release was planned to be October.

Thanks for clearing that up.

I wrote back asking if Paxil was currently recommended for use in children between the ages of 7-17 in Japan?